Company intelligence / Profile preview

Yuanpin Cellular Biotechnology Group

Changsha, Hunan, China
Ownership
Private
Employees
~500
Development stage
Other
01

Overview

Yuanpin Cellular Biotechnology Group is a leading Chinese biotechnology company specializing in the research, development, and industrialization of cell-based therapies and regenerative medicine. Based in Changsha, the company operates the 'China Origin' cell bank, a large-scale facility for the storage and processing of stem cells and immune cells. Their business model encompasses the entire cell industry chain, including cell storage, technology R&D, clinical transformation, and health management services. Yuanpin is actively advancing several cell-derived products through clinical trials, focusing on indications such as osteoarthritis and autoimmune diseases.

Therapeutic areas
EndocrinologyGastroenterologyRheumatologyOtherImmunology
Modalities
Cell therapyStem cell therapyNK cell therapyExosome-based therapy
Industry
Biotech
02

Drug pipeline

1 asset

umbilical cord-derived mesenchymal stem cells (3D)

Preclinical
03

Partnerships

Central South UniversityXiangya Hospital

Beyond the preview

Go deeper on Yuanpin Cellular Biotechnology Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yuanpin Cellular Biotechnology Group.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call